Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-14

FDA Approved: TREPROSTINIL — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for TREPROSTINIL water solution from Sandoz Inc, approving a new formulation of treprostinil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Treprostinil (treprostinil)

Snippet

SUPPL AP for TREPROSTINIL (TREPROSTINIL)